3 Dividend Growth Stocks You Can Buy and Hold Forever
These healthcare stocks have fantastic dividend track records.
AbbVie (ABBV) Outperforms Broader Market: What You Need to Know
In the closing of the recent trading day, AbbVie (ABBV) stood at $189.65, denoting a +0.94% change from the preceding trading day.
AbbVie: Expect A Beat-And-Raise Q3 2024
AbbVie will report Q3 2024 results next week and I expect to see a beat-and-raise quarter. The outperformance should be driven by top growth products Skyrizi and Rinvoq, the strong performance of n...
AbbVie: Strong Dividends But Humira Disappoints
Healthcare stocks are both defensive and present a mean reversion opportunity, making them attractive for risk-averse investors. Revenue exposure analysis shows consistent growth trends over 10 yea...
BOTOX® Cosmetic (onabotulinumtoxinA) Receives FDA Approval for Moderate to Severe Vertical Bands Connecting the Jaw and Neck (Platysma Bands)
The Only Product of Its Kind Approved for Use in Four Aesthetic Indications: Temporary Improvement in the Appearance of Moderate to Severe Forehead Lines, Frown Lines, Crow's Feet Lines, and Now Pl...
AbbVie (ABBV) Falls More Steeply Than Broader Market: What Investors Need to Know
AbbVie (ABBV) reachead $188.57 at the closing of the latest trading day, reflecting a -0.99% change compared to its last close.
There Are Only 28 S&P 500 Companies Warren Buffett Can't Buy Outright. Here's the Best of the Bunch for Income Investors.
This Dividend King is beyond Buffett's reach to fully acquire and is a great pick for income investors.
AbbVie Stock Eyes New Highs: Analysts See Strong Growth Potential
AbbVie NYSE: ABBV spooked the market in early October, but the sell-off is a buying opportunity. The critical takeaway is that only the earnings guidance was altered; the trim was small and offset ...
3 Magnificent Dividend Stocks to Buy in October
These dividend stocks are great picks as the fall season gets underway.
Billionaires Are Loading Up on This High-Yield Dividend Stock. Should You?
Declining earnings haven't scared billionaire investors away from this stock.
2 Top Dividend Stocks Yielding 3% or More to Buy Without Hesitation Right Now
These companies can lend growth and dividend returns to a long-term investor's portfolio.
AbbVie Cuts 2024 Earnings Guidance to Include Acquisition Costs
ABBV lowers adjusted earnings guidance for 2024 from $10.71-$10.91 per share to $10.67-$10.87 to account for acquisition costs.
AbbVie (ABBV) Suffers a Larger Drop Than the General Market: Key Insights
AbbVie (ABBV) closed the most recent trading day at $195.45, moving -0.7% from the previous trading session.
AbbVie cuts 2024 profit forecast on R&D expenses
AbbVie on Thursday lowered its forecast for 2024 adjusted profit, citing $82 million in milestones, and research and development expenses related to acquisitions.
3 Top Pharma Stocks to Buy in October 2024
The pharmaceutical industry plays a crucial role in most of our everyday lives.
Related Companies